Article Figures & Data
Figures
- Figure 1.
The relation between patient global health assessment and fatigue (left) and pain (right) according to physician (MD) global activity status. The vertical line separates patients in ACR/EULAR remission (left of line) from those not in remission. A small amount of random noise is added to the data points to improve visibility by minimizing overlap. VAS: visual analog scale; HAQ: Health Assessment Questionnaire.
- Figure 2.
The relation between the levels of physician global activity and patient global health assessment for all patients (right panel) and for the subset of patients for whom erythrocyte sedimentation rate (ESR) was available (left panel). A small amount of vertical random noise is added to the physician global activity points to improve visibility by minimizing overlap. The vertical line separates patients in ACR/EULAR remission (left of line) from those not in remission. RA: rheumatoid arthritis.
Tables
- Table 1.
Comparison between American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) remission-positive and remission-negative patients who satisfy ACR/EULAR swollen and tender joint criteria (≤ 1), but differ concerning the patient global criterion (≤ 1). Data are mean (SD) unless otherwise indicated.
Variable ACR (Global > 1) Remission (−), n = 60 (77.9%) ACR (Global ≤ 1) Remission (+), n = 17 (22.1%) p Age, yrs 59.1 (12.5) 63.9 (18.8) 0.226 Sex, % male 45.8 35.3 0.443 Global severity (0–10) 3.3 (1.9) 0.4 (0.4) < 0.001 Pain (0–10) 3.2 (1.9) 1.6 (2.3) 0.004 Fatigue (0–10) 4.3 (2.4) 1.4 (1.6) < 0.001 HAQ-II (0–3) 0.8 (0.7) 0.3 (0.3) 0.002 MD global activity (0–10) 0.86 (0.5) 0.94 (0.8) 0.632 MD 28 tender joint count 0.25 (0.4) 0.00 (0.0) 0.021 MD 28 swollen joint count 0.13 (0.3) 0.06 (0.2) 0.089 MD global activity = 0 (%) 77.6 22.4 0.096 ACR/EULAR AE-4 remission (%) 0.0 76.5 — -
HAQ-II: Health Assessment Questionnaire functional disability assessment; AE-4: ACR/EULAR-4 variable criteria.
-
- Table 2.
Effect of predictor variables on risk of high patient global score and failure to satisfy American College of Rheumatology/European League Against Rheumatism remission criteria.
Variable OR (95% CI) p Painful joints and nonarticular regions (0–44) 1.49 (1.10, 2.28) 0.005 Painful joints (0–28) 1.49 (1.05, 2.30) 0.018 Painful nonarticular regions (0–16) 3.25 (1.03, 27.30) 0.040 Specific painful regions Hands and wrists 5.63 (1.15, 55.06) 0.028 Low back 6.95 (1.06, ∞) 0.041 Shoulders 4.36 (0.57, 199.65) 0.250 Elbows 2.00 (0.26, ∞) 0.553 Hip 1.55 (0.18, ∞) 0.721 Upper back 1.55 (0.18, ∞) 0.721 Knees 1.39 (0.36, 6.64) 0.848 Feet 1.28 (0.33, 6.16) 0.955 Buttocks 0.69 (0.05, ∞) 1.000 Groin 1.77 (0.19, 86.81) 1.000 Jaw 0.28 (0.007, ∞) 1.000 Neck 1.45 (0.15, 73.04) 1.000 ESR ≥ 20 (male), ≥ 30 (female) 0.40 (0.03, ∞) 1.000* VAS fatigue (0–10) 2.19 (1.45, 3.77) 0.000 VAS pain (0–10) 1.68 (1.18, 2.58) 0.002 HAQ-II disability (0–3) 9.33 (2.22, 54.42) 0.001 -
↵* n = 33. ESR: erythrocyte sedimentation rate; VAS: visual analog scale; HAQ-II: Health Assessment Questionnaire functional disability assessment.
-
Factor Most Important Factor, % Contributing Factor, % Not a Contributing Factor, % Pain 38.2 59.7 40.3 Functional limitations 25.0 52.0 48.1 Fatigue 26.5 59.7 40.3 Mood 2.9 14.3 85.7 Medication side effects 1.5 15.6 84.4 Cost of medical care 2.9 11.7 88.3 Work disability 1.5 11.7 88.3 Other 1.5 3.9 96.1
In this issue
